Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Joseph Noonan

Psychiatry Southington, CT Medical Doctor

NPI 1265544779 CMS profile 284687

51 North Main St, Suite 2C, Southington, CT 06489

Open in the dashboard

General payments

$3,679

102 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Joseph Noonan of Southington, CT is reported in the CMS Open Payments database as having received $3,679 across 102 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $31 2
2022 General $974 31
2021 General $881 34
2020 General $305 11
2019 General $1,487 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Noonan
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Joseph Noonan were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Joseph Noonan Psychiatry median Middle half National median
2019 $1,487 $184 $59–$605 $163
2020 $305 $119 $36–$372 $114
2021 $881 $143 $43–$576 $132
2022 $974 $153 $50–$590 $149
2023 $31 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Otsuka America Pharmaceutical, Inc. $826 9 payments
  2. Janssen Pharmaceuticals, Inc $561 18 payments
  3. Neurocrine Biosciences, Inc. $521 11 payments
  4. Alkermes, Inc. $479 10 payments
  5. ITI, Inc. $339 15 payments
  6. Sunovion Pharmaceuticals Inc. $186 10 payments
  7. Allergan Inc. $155 3 payments
  8. Teva Pharmaceuticals USA, Inc. $146 4 payments
  9. AbbVie, Inc. $140 7 payments
  10. Indivior Inc. $97 4 payments
  11. Other $229 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $3,608 101 payments
  2. Education $71 1 payment
Products named General payments · program years 2019–2023
  1. REXULTI $504 5 payments
  2. SPRAVATO $341 13 payments
  3. CAPLYTA $339 15 payments
  4. ABILIFY MAINTENA $322 4 payments
  5. INVEGA SUSTENNA $316 11 payments
  6. ARISTADA INITIO $299 6 payments
  7. ARISTADA Cns $299 6 payments
  8. ARISTADA Cns $299 6 payments
  9. ARISTADA Cns $299 6 payments
  10. ARISTADA Cns $299 6 payments
  11. Other $2,293 74 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

102 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record